Founded in 2018, PiVOT is the leading and largest Philippine Contract Research Organization (CRO). Our mission is to help develop life-changing treatments for Filipino patients from all walks of life and put the Philippines on the map for world-class clinical trials and impactful research.

The PiVOT

Difference

Local Expertise, Global Standards

ICH-GCP–trained teams with deep site relationships and regulatory fluency in the Philippines.

Dedicated, certified professionals

All CRAs are full-time and GCP-certified, ensuring consistency, compliance and accountability at every phase.

Focused on late-phase success

Proven delivery of Phase III and IV trials across oncology, infectious disease, and other high-impact areas.

Company Milestones

2025

PiVOT leaders elected to the Philippine Clinical Research Professionals (PCRP) board of directors

2024

Joined ACRP
1st overseas FSP engagement

2023

Joined the Global Life Sciences Alliance (GLSA), a network of global CROs
1st DIA attendance (2022)
1st Pinnacle

2022

Complete 5 COVID-19 FDA applications, all approved

2021

Secured first COVID-19 PH FDA clinical trial approval

2020

Completed First FDA Clinical Trial Submissions and Approvals

2019

Started operations on
Pi Day (3.14)

2018

Incorporated as Pi Health Inc. and registered as a CRO with a License to Operate (LTO) by the Philippine Food and Drug Administration

2018

Incorporated as Pi Health Inc. and registered as a CRO with a License to Operate (LTO) by the Philippine Food and Drug Administration

2019

Started operations on
Pi Day (3.14)

2020

Completed First FDA Clinical Trial Submissions and Approvals

2021

Secured first COVID-19 PH FDA clinical trial approval

2022

Complete 5 COVID-19 FDA applications, all approved

2023

Joined the Global Life Sciences Alliance (GLSA), a network of global CROs
1st DIA attendance (2022)
1st Pinnacle

2024

Joined ACRP
1st overseas FSP engagement

2025

PiVOT leaders elected to the Philippine Clinical Research Professionals (PCRP) board of directors